Annual SG&A
$19.75 M
-$8.91 M-31.09%
30 June 2024
Summary:
Renalytix annual selling, general & administrative expenses is currently $19.75 million, with the most recent change of -$8.91 million (-31.09%) on 30 June 2024. During the last 3 years, it has risen by +$4.32 million (+27.95%). RNLX annual SG&A is now -50.03% below its all-time high of $39.52 million, reached on 30 June 2022.RNLX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$3.27 M
-$1.23 M-27.29%
30 September 2024
Summary:
Renalytix quarterly selling, general & administrative expenses is currently $3.27 million, with the most recent change of -$1.23 million (-27.29%) on 30 September 2024. Over the past year, it has dropped by -$2.79 million (-46.01%). RNLX quarterly SG&A is now -69.74% below its all-time high of $10.81 million, reached on 31 March 2022.RNLX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$751.47 M
-$28.03 M-3.87%
30 September 2024
Summary:
Renalytix TTM selling, general & administrative expenses is currently -$751.47 million, with the most recent change of -$28.03 million (-3.87%) on 30 September 2024. Over the past year, it has dropped by -$777.94 million (-2938.84%). RNLX TTM SG&A is now -26019.88% below its all-time high of $39.64 million, reached on 30 September 2022.RNLX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNLX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -31.1% | -46.0% | -2938.8% |
| 3 y3 years | +27.9% | -59.8% | -3963.2% |
| 5 y5 years | +621.6% | +290.8% | -10000.0% |
RNLX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -50.0% | +27.9% | -69.7% | +48.2% | -212.8% | at low |
| 5 y | 5 years | -50.0% | +621.6% | -69.7% | +497.9% | -1328.2% | at low |
| alltime | all time | -50.0% | +621.6% | -69.7% | +497.9% | <-9999.0% | at low |
Renalytix Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.27 M(-27.3%) | $13.83 M(-16.8%) |
| June 2024 | $19.75 M(-31.1%) | $4.50 M(+16.7%) | $16.62 M(-10.8%) |
| Mar 2024 | - | $3.85 M(+74.6%) | $18.63 M(-14.8%) |
| Dec 2023 | - | $2.21 M(-63.6%) | $21.87 M(-17.4%) |
| Sept 2023 | - | $6.06 M(-6.9%) | $26.47 M(-7.6%) |
| June 2023 | $28.66 M(-27.5%) | $6.51 M(-8.3%) | $28.66 M(-12.3%) |
| Mar 2023 | - | $7.09 M(+4.2%) | $32.67 M(-10.2%) |
| Dec 2022 | - | $6.81 M(-17.5%) | $36.38 M(-8.2%) |
| Sept 2022 | - | $8.25 M(-21.5%) | $39.64 M(+0.3%) |
| June 2022 | $39.52 M | $10.51 M(-2.7%) | $39.52 M(+40.2%) |
| Mar 2022 | - | $10.81 M(+7.3%) | $28.19 M(+23.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | $10.07 M(+23.8%) | $22.93 M(+17.9%) |
| Sept 2021 | - | $8.13 M(-1089.3%) | $19.45 M(+26.0%) |
| June 2021 | $15.44 M(+168.5%) | -$822.00 K(-114.8%) | $15.44 M(-15.4%) |
| Mar 2021 | - | $5.55 M(-15.9%) | $18.24 M(+30.2%) |
| Dec 2020 | - | $6.59 M(+60.2%) | $14.01 M(+55.2%) |
| Sept 2020 | - | $4.12 M(+107.9%) | $9.03 M(+57.0%) |
| June 2020 | $5.75 M(+110.1%) | $1.98 M(+50.0%) | $5.75 M(+52.5%) |
| Mar 2020 | - | $1.32 M(-18.2%) | $3.77 M(+53.9%) |
| Dec 2019 | - | $1.61 M(+92.7%) | $2.45 M(+192.7%) |
| Sept 2019 | - | $837.00 K(+123.8%) | $837.00 K(+123.8%) |
| June 2019 | $2.74 M | - | - |
| June 2018 | - | $374.00 K | $374.00 K |
FAQ
- What is Renalytix annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Renalytix?
- What is Renalytix annual SG&A year-on-year change?
- What is Renalytix quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Renalytix?
- What is Renalytix quarterly SG&A year-on-year change?
- What is Renalytix TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Renalytix?
- What is Renalytix TTM SG&A year-on-year change?
What is Renalytix annual selling, general & administrative expenses?
The current annual SG&A of RNLX is $19.75 M
What is the all time high annual SG&A for Renalytix?
Renalytix all-time high annual selling, general & administrative expenses is $39.52 M
What is Renalytix annual SG&A year-on-year change?
Over the past year, RNLX annual selling, general & administrative expenses has changed by -$8.91 M (-31.09%)
What is Renalytix quarterly selling, general & administrative expenses?
The current quarterly SG&A of RNLX is $3.27 M
What is the all time high quarterly SG&A for Renalytix?
Renalytix all-time high quarterly selling, general & administrative expenses is $10.81 M
What is Renalytix quarterly SG&A year-on-year change?
Over the past year, RNLX quarterly selling, general & administrative expenses has changed by -$2.79 M (-46.01%)
What is Renalytix TTM selling, general & administrative expenses?
The current TTM SG&A of RNLX is -$751.47 M
What is the all time high TTM SG&A for Renalytix?
Renalytix all-time high TTM selling, general & administrative expenses is $39.64 M
What is Renalytix TTM SG&A year-on-year change?
Over the past year, RNLX TTM selling, general & administrative expenses has changed by -$777.94 M (-2938.84%)